CYCLOSPORINEMULSION

Patent europeic · EP2621469 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2621469
Numer da la dumonda
EP11767671
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
30-09-2011
Publitgà
07-08-2013
Concedì
20-07-2016
La protecziun finescha il pli tard
29-09-2031
Proxima taxa annuala scadenta
30-09-2027
Classas IPC
A61K 9/107 (2006.01)
A61K 38/13 (2006.01)
Prioritad
US 388633 P 01.10.2010
DK 201000891 U 01.10.2010
Dumonda PCT
PCT/EP2011/067117 30.09.2011
Publicaziun PCT
WO2012/042023 05.04.2012
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-10-2026

    Next annual fee due on

    Next annual fee due on
    30.09.2026 → 30.09.2027

    Published in Swissreg on 01.10.2026

  2. 01-10-2025

    Next annual fee due on

    Next annual fee due on
    30.09.2025 → 30.09.2026

    Published in Swissreg on 01.10.2025

  3. 03-10-2024

    Midada

    Published in Swissreg on 03.10.2024

  4. 01-10-2023

    Midada

    Published in Swissreg on 01.10.2023

  5. 01-10-2022

    Midada

    Published in Swissreg on 01.10.2022

  6. 21-07-2021

    Adressa midada

    Owner
    Neurovive Pharmaceutical AB, Biomedical Center D10, 221 84 Lund, Sweden → Abliva AB, Medicon Village, 223 81 Lund, Sweden

    Published in Swissreg on 21.07.2021

  7. 20-07-2016

    Concedì

    Published in Swissreg on 20.07.2016

Partidas

Possessur

Abliva AB

Medicon Village, 223 81 Lund, SE

Inventur

ELMÉR, Eskil

S-224 65 Lund, SE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.